# IMPAACT 1077HS: Examining Benefits of HAART Continuation in Postpartum Women

> **NCT00955968** · PHASE4 · COMPLETED · sponsor: **International Maternal Pediatric Adolescent AIDS Clinical Trials Group** · enrollment: 1653 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Highly active antiretroviral therapy (HAART)

## Key facts

- **NCT ID:** NCT00955968
- **Lead sponsor:** International Maternal Pediatric Adolescent AIDS Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01-01
- **Primary completion:** 2016-08-31
- **Final completion:** 2016-08-31
- **Target enrollment:** 1653 (ACTUAL)
- **Last updated:** 2023-08-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00955968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00955968, "IMPAACT 1077HS: Examining Benefits of HAART Continuation in Postpartum Women". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00955968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*